Micafungin Accord-Uk

Micafungin, the active ingredient in Micafungin Accord-Uk, is an echinocandin presented as an injectable solution for intravenous use. It treats invasive candidiasis, esophageal candidiasis, candidemia, and is used for prophylaxis of fungal infections in hematopoietic stem cell transplantation.

GNH USA supplies Micafungin Accord-Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product complies with EU market standards and is manufactured under GMP conditions. It is distributed through a secure cold‑chain logistics network to maintain stability.

Micafungin is an echinocandin antifungal that inhibits fungal cell wall synthesis.

- Invasive candidiasis: effective treatment of bloodstream and deep‑tissue Candida infections. - Esophageal candidiasis: resolves mucosal infection of the esophagus caused by Candida species. - Prophylaxis in hematopoietic stem cell transplantation: prevents invasive fungal infections in high‑risk transplant recipients.

Micafungin may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Infusion‑related reactions: flushing, chills, or rigors during administration. - Fever: transient elevations in body temperature. - Nausea: mild gastrointestinal discomfort. - Headache: occasional mild to moderate headache. - Elevated liver enzymes: transient increases in ALT or AST. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Hypersensitivity reactions: anaphylaxis or severe skin reactions. - Severe hepatic dysfunction: marked elevation of liver enzymes or hepatitis. - Renal impairment: acute kidney injury or worsening renal function. - Severe hypotension: marked drop in blood pressure during infusion. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: rare severe skin disorders. - Cardiac arrhythmia: uncommon but serious rhythm disturbances.

Prior to initiating Micafungin therapy, clinicians should consider several precautionary measures. - Pregnancy: safety category unknown; use only if potential benefit justifies the risk. - Renal impairment: assess renal function and adjust dosing as needed. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Concomitant azole antifungals: potential interaction may increase Micafungin levels; monitor closely. - Patients with known hypersensitivity to echinocandins: avoid use. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Micafungin can interact with other medicines